Avecho Biotechnology (ASX:AVE)
ASX announcement history & article coverage
Transparent by design.
Announcments by Avecho Biotechnology (ASX:AVE) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
September 2026 Quarterly Activities Report & Appendix 4C
Avecho resumes final Phase III insomnia trial recruitment as licensing talks advance
Change of Chief Financial Officer
Response to ASX Price Query
Avecho says it has no explanation for sharp share price and volume increase
Avecho to present at the Canaccord Drug and Device Confe
Avecho to present at the ASX SMIDcaps Conference
Avecho enters final stage of Phase III insomnia trial
Avecho restarts recruitment for final Phase III insomnia trial after positive interim results
Notification regarding unquoted securities - AVE
Appendix 4D and Half-year Financial Report
Avecho strengthens BD capability with senior appointment
Small Holding Share Sale Facility Completion
Japanese patent granted for CBD capsule
June 2026 Quarterly Activities Report & Appendix 4C
Avecho reports positive Phase III insomnia trial interim results and strengthens financial position
